ArticleJACC. Clinical electrophysiology2024
Serum Potassium Monitoring Using AI-Enabled Smartwatch Electrocardiograms.
Article in JACC. Clinical electrophysiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Impact of digital health technology-based nutritional interventions on the nutritional status of hemodialysis patients: a systematic review and meta-analysis.Frontiers in nutrition · 2025Pooled it
- Bridging the gap from clinical to home ECG: quantifying and overcoming accuracy loss in AI-enabled single-lead ECG models.NPJ digital medicine · 2026Article
- Review
- Cardiovascular disease prevention in China: challenges and opportunities in the artificial intelligence-enabled digital health era.Nature reviews. Cardiology · 2026Review
- Integrating multimodal intelligence in heart failure: AI-driven risk prediction, precision diagnosis, phenotyping, personalized treatment, and prognosis.Chinese medical journal · 2026Review
- Multi-modal deep-learning troponin prediction from electrocardiograms and demographic data.European heart journal. Digital health · 2026Article
- Transforming nephrology through artificial intelligence: a state-of-the-art roadmap for clinical integration.Clinical kidney journal · 2026Review
- Factors associated with physician modifications to automated ECG interpretations.European heart journal. Digital health · 2026Article
- Artificial intelligence-enabled electrocardiography from scientific research to clinical application.EMBO molecular medicine · 2026Review
- Current and Future Applications of AI-Driven Predictive Modeling and a Proposed Framework for AI-Bioprognostics in Kidney Care.Risk management and healthcare policy · 2026Review
- A new electrocardiographic evaluation in hyperkalemia: frontal QRS-T angle.Irish journal of medical science · 2025Article
- Artificial Intelligence and ECG: A New Frontier in Cardiac Diagnostics and Prevention.Biomedicines · 2025Review
- A deep learning phenome wide association study of the electrocardiogram.European heart journal. Digital health · 2025Article
- Monitoring serum potassium concentration in patients with severe hyperkalemia: the role of bloodless artificial intelligence-enabled electrocardiography.Clinical kidney journal · 2025Article
- Device-based Strategies for Monitoring Congestion and Guideline-directed Therapy in Heart Failure: The Who, When and How of Personalised Care.Cardiac failure review · 2025Review
- Artificial intelligence in chronic kidney disease: Bibliometric and visual analysis of trends and future directions.Digital healthArticle
Corrections and comments
- Commented on by
Authors and funding
11 authors.
Funding
Abstract
backgroundHyperkalemia, characterized by elevated serum potassium levels, heightens the risk of sudden cardiac death, particularly increasing risk for individuals with chronic kidney disease and end-stage renal disease (ESRD). Traditional laboratory test monitoring is resource-heavy, invasive, and unable to provide continuous tracking. Wearable technologies like smartwatches with electrocardiogram (ECG) capabilities are emerging as valuable tools for remote monitoring, potentially allowing for personalized monitoring with artificial intelligence (AI)-ECG interpretation.
objectivesThe purpose of this study was to develop an AI-ECG algorithm to predict serum potassium level in ESRD patients with smartwatch-generated ECG waveforms.
methodsA cohort of 152,508 patients with 293,557 ECGs paired serum potassium levels obtained within 1 hour at Cedars Sinai Medical Center was used to train an AI-ECG model ("Kardio-Net") to predict serum potassium level. The model was further fine-tuned on 4,337 ECGs from 1,463 patients with ESRD using inputs from 12- and single-lead ECGs. Kardio-Net was evaluated in held-out test cohorts from Cedars Sinai Medical Center and Stanford Healthcare (SHC) as well as a prospective international cohort of 40 ESRD patients with smartwatch ECGs at Chang Gung Memorial Hospital.
resultsThe Kardio-Net, when applied to 12-lead ECGs, identified severe hyperkalemia (>6.5 mEq/L) with an AUC of 0.852 (95% CI: 0.745-0.956) and a mean absolute error (MAE) of 0.527 mEq/L. In external validation at SHC, the model achieved an AUC of 0.849 (95% CI: 0.823-0.875) and an MAE of 0.599 mEq/L. For single-lead ECGs, Kardio-Net detected severe hyperkalemia with an AUC of 0.876 (95% CI: 0.765-0.987) in the primary cohort and had an MAE of 0.575 mEq/L. In the external SHC validation, the AUC was 0.807 (95% CI: 0.778-0.835) with an MAE of 0.740 mEq/L. Using prospectively obtained smartwatch data, the AUC was 0.831 (95% CI: 0.693-0.975), with an MAE of 0.580 mEq/L.
conclusionsWe validate a deep learning model to predict serum potassium levels from both 12-lead ECGs and single-lead smartwatch data, demonstrating its utility for remote monitoring of hyperkalemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.